Citizens JMP Reiterates Market Outperform Rating on Integra LifeSciences (IART)
Tweet Send to a Friend
Citizens JMP analyst David Turkaly reiterated a Market Outperform rating and $25.00 price target on Integra LifeSciences (NASDAQ: IART).The analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
